Immatics IMTX
NASDAQ IMTX
$9.56 +0.10 (+1.06%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immatics (IMTX) Other Accumulated Expenses (2019 - 2026)

Immatics (IMTX) posted Other Accumulated Expenses of $6.5 million for Q4 2025, up 21.45% sequentially from $5.4 million in Q3 2025, and down 10.25% YoY from $7.3 million in Q4 2024.

Analysis

Immatics (IMTX) Other Accumulated Expenses (2019 - 2026) Analysis & Trends

Immatics has reported Other Accumulated Expenses for 7 years, with the latest figure at $6.5 million in Q4 2025.

  • Quarterly Other Accumulated Expenses fell 10.25% year-over-year to $6.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.5 million (down 10.25% YoY) and the FY2025 annual result came in at $6.3 million, down 13.99% from the prior year.
  • Other Accumulated Expenses improved to $6.5 million in Q4 2025 per IMTX's latest filing, from $5.4 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $16.6 million in Q3 2024 and troughed at $1.7 million in Q1 2021.
  • A 5-year average of $6.7 million and a median of $7.1 million in 2024 frame the typical range for Other Accumulated Expenses.
  • The sharpest annual moves came in 2021 and 2023: Other Accumulated Expenses sank 85.38% in 2021, then soared 377.4% in 2023.
  • Over 5 years, Other Accumulated Expenses stood at $2.9 million in 2021, then surged by 227.31% to $9.6 million in 2022, then increased by 5.26% to $10.1 million in 2023, then retreated by 27.7% to $7.3 million in 2024, then fell by 10.25% to $6.5 million in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods registered $6.5 million, $5.4 million, and $7.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Immatics 1.17 Bn 711.21 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.58 Mn
Mar 31, 2026 6.04 Mn
Dec 31, 2025 6.53 Mn
Sep 30, 2025 5.37 Mn
Jun 30, 2025 7.65 Mn
Mar 31, 2025 6.99 Mn
Dec 31, 2024 7.27 Mn
Sep 30, 2024 16.64 Mn
Jun 30, 2024 10.79 Mn
Mar 31, 2024 10.42 Mn
Dec 31, 2023 10.06 Mn
Sep 30, 2023 8.29 Mn
Jun 30, 2023 8.63 Mn
Mar 31, 2023 8.57 Mn
Dec 31, 2022 9.56 Mn
Sep 30, 2022 4.40 Mn
Jun 30, 2022 3.11 Mn
Mar 31, 2022 1.80 Mn
Dec 31, 2021 2.92 Mn
Sep 30, 2021 1.73 Mn